To study the efficacy of Dhatryadi kwath and Vasadi kwath in management of Vatarakta (Gout).

Phase 3

Not yet recruiting

• Conditions: Chronic gout, unspecified. Ayurveda Condition: VATARAKTAM,

• Registration Number: CTRI/2023/08/056963
• Lead Sponsor: Vd Ravindra Namdev Sagbhor

Brief Summary

The aim of study is to compare clinically the efficacy of Dhatryadi kwath with madhu and Vasadi kwath with Erandtail in management of Vatarakta (gout). To study in detail about vatarakta according to ayurvedic classics and observe any adverse effects. The trial will be conducted on 150 patients showing sign and symptoms of vatarakta in 02 groups, also serum uric acid level will be checked on the day of patient enrollment. Medicine will be given for 90 days, at the interval of 30 days patients will be assess the effect of therapy on objective parameters as well as subjective parameters. after 90 days of trial collected data of subjective and  objective parameters will be statistically assess and conclusion will be drawn.

Detailed Description

Not available

Study Timeline

• Study Start: 2023-04-09
• Last Update Posted: 2023-07-29

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 150

Inclusion Criteria

• 1.Patient having signs and symptoms of vatarakta like shotha,kathinya,vedanadhikya,daha,Tod,shyavata/tamrata,spuran.
• Patient of any sex, religion and socio-economic status.
• 2.newly diagnosed patient.
• 3.Patient with serum uric acid >7mg/dl in male and 6mg/dl in female.

Exclusion Criteria

• 1.Pathophysiology or genetic syndrome associated with vatarakta.
• 2.patient in serious symptoms like paak,khanja,pangulya and sandhivakrata are excluded.
• 3 malignancy, poorly controlled DM,HTN.
• 4.symptomatic patient with clinical evidence of heart failure.
• 5.complicated patient having target organ damage.
• 6.alcoholic and drug abusers, pregnant and lactating women.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Reduction in the classical sign and symptoms of vatarakta.	30th, 60th, 90th day

Secondary Outcome Measures

Name	Time	Method
1.To assess efficacy of Dhatryadi kwath & Vasadi kwath in management of Vatarakta.	2.To assess any adverse effects of Dhatryadi kwath & Vasadi kwath in management of Vatarakta.

Trial Locations

Locations (1)

Seth Tarachand Ramnath Dharmarth Ayurvedic Rugnalaya,Pune; 🇮🇳 Pune, MAHARASHTRA, India

Seth Tarachand Ramnath Dharmarth Ayurvedic Rugnalaya,Pune

🇮🇳Pune, MAHARASHTRA, India

Vd Ravindra Namdev Sagbhor

Principal investigator

9763444204

dr.ravisagbhor@gmail.com